The primary care physician and activist Dr. Gordon Schiff advises those advocating for systemic change to set priorities, work with others, and realize the power of small actions.
AMA J Ethics. 2015;17(5):465-468. doi:
10.1001/journalofethics.2015.17.5.mnar1-1505.
This month, AMA Journal of Ethics' theme editor, Nadi N. Kaonga, a medical student and predoctoral candidate at Tufts University in Boston, interviewed Gordon D. Schiff, MD, on reframing professional boundaries in the patient-physician relationship.
The high price of cancer drugs in the US relative to European countries with universal health care raises ethical issues of access, financial burden on patients, and unsustainability of the health care system.
AMA J Ethics. 2015;17(8):750-753. doi:
10.1001/journalofethics.2015.17.8.nlit1-1508.
The Orphan Drug Act of 1983 provides incentives to encourage the development of drugs for rare diseases, but available orphan drugs tend to be expensive and targeted to the more common of the rare diseases.
AMA J Ethics. 2015;17(8):776-779. doi:
10.1001/journalofethics.2015.17.8.pfor2-1508.
If a medical decision about high-value care involves a conflict between the principles of beneficence and justice, an explicit analysis of the individual case is necessary to ensure that the interests of both the patient and society are served.
AMA J Ethics. 2015;17(11):1022-1027. doi:
10.1001/journalofethics.2015.17.11.ecas1-1511.